Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-29 @ 6:32 AM
Study NCT ID:
NCT05124561
Status:
WITHDRAWN
Last Update Posted:
2023-06-18
First Post:
2021-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Sponsor:
CanSino Biologics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-04-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-20
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-17
First Submit QC Date:
None
Study First Post Date:
2021-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-14
Last Update Post Date:
2023-06-18
Last Update Post Date Type:
ACTUAL